Cargando…
Perspectives on immunotherapy via oncolytic viruses
BACKGROUND: With few exceptions, current chemotherapy and radiotherapy protocols only obtain a slightly prolonged survival with severe adverse effects in patients with advanced solid tumors. In particular, most solid malignancies not amenable to radical surgery still carry a dismal prognosis, which...
Autores principales: | Reale, Alberto, Vitiello, Adriana, Conciatori, Valeria, Parolin, Cristina, Calistri, Arianna, Palù, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371415/ https://www.ncbi.nlm.nih.gov/pubmed/30792754 http://dx.doi.org/10.1186/s13027-018-0218-1 |
Ejemplares similares
-
Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer
por: Reale, Alberto, et al.
Publicado: (2023) -
Why Cells and Viruses Cannot Survive without an ESCRT
por: Calistri, Arianna, et al.
Publicado: (2021) -
A clinical trial investigating biodistribution and shedding of an oncolytic virus
por: Reale, Alberto, et al.
Publicado: (2019) -
Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
por: Reale, Alberto, et al.
Publicado: (2021) -
View and review on viral oncology research
por: Bergonzini, Valeria, et al.
Publicado: (2010)